Cargando…
Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
CYP21A2 deficiency represents 95% of congenital adrenal hyperplasia (CAH) cases, a group of genetic disorders that affect steroid biosynthesis. The genetic and functional analysis provide critical tools to elucidate complex CAH cases. One of the most accessible tools to infer the pathogenicity of ne...
Autores principales: | Prado, Mayara J., Ligabue-Braun, Rodrigo, Zaha, Arnaldo, Rossetti, Maria Lucia Rosa, Pandey, Amit V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579345/ https://www.ncbi.nlm.nih.gov/pubmed/36278220 http://dx.doi.org/10.3389/fphar.2022.931089 |
Ejemplares similares
-
Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations
por: Prado, Mayara J., et al.
Publicado: (2021) -
Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
por: Chi, Dung V., et al.
Publicado: (2019) -
Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
por: Marumudi, Eunice, et al.
Publicado: (2012) -
Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene
por: Rabbani, Bahareh, et al.
Publicado: (2011) -
CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
por: Umaña-Calderón, Andrés, et al.
Publicado: (2021)